Alliance Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alliance Private Wealth's BMY Position: Q2 2026 in Review
Alliance Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 6.5% in Q2 2026, selling an estimated $63.7K and leaving 15,897 shares worth $916K. The position accounts for 0.32% of the portfolio, ranked #60.
Alliance Private Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.03M in Q1 2026. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Alliance Private Wealth held 15,897 shares of Bristol-Myers Squibb worth $916K as of Q2 2026.
- Alliance Private Wealth sold 1,110 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.7K.
- Bristol-Myers Squibb made up 0.32% of Alliance Private Wealth's portfolio in Q2 2026, its #60 holding.
- Alliance Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Alliance Private Wealth's Bristol-Myers Squibb position peaked at $1.03M in Q1 2026.
- 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Alliance Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.